BioCentury
ARTICLE | Company News

Navidea, Rheumco deal

August 11, 2014 7:00 AM UTC

Navidea and Rheumco formed a JV to develop and commercialize radiolabeled diagnostics and therapeutics for rheumatologic and arthritic diseases using Navidea’s Manocept CD206 macrophage targeting pla...